USPSTF Issues a Final Recommendation Giving PrEP an “A” Rating

Recently, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation, giving an “A” rating to preexposure prophylaxis (PrEP) treatment. Read this blog post from UBA to learn what this final recommendation means.

The U.S. Preventive Services Task Force (USPSTF) published a final recommendation that gives an “A” rating to preexposure prophylaxis (PrEP) treatment. This means that the USPSTF recommends offering PrEP with effective antiretroviral therapy to people at high risk of HIV acquisition.

Group health plans and insurers subject to the preventive services coverage mandate must provide coverage for evidence-based items or services with an A or B rating recommended by the USPSTF without imposing copayments, coinsurance, deductibles, or other cost-sharing requirements when delivered by in-network providers. Group health plans and insurers subject to the preventive services coverage mandate generally must cover preventive services that are recommended by the USPSTF one year after the recommendation is issued.